Study of Formulation, Characteristics, and Evaluation of Self Nanoemulsifying Drug Delivery System (SNEDDS) for Atorvastatin Calcium

Nurfianti Silvia, Taofik Rusdiana, Dolih Gozali, Patihul Husni

Abstract

A Self-Nanoemulsifying Drug Delivery System (SNEDDS) is a formulation approach used in the pharmaceutical and biotechnology industries to improve the solubility and bioavailability of poorly water-soluble drugs. Atorvastatin calcium has limited water solubility, which can affect its bioavailability when administered orally. Its solubility can be enhanced by various formulation techniques, such as the use of self-nanoemulsifying drug delivery systems (SNEDDS). The purpose of this study is to determine the formulation and characterization of SNEDDS and determine how it affects the bioavailability of atorvastatin calcium. The data were collected from published journals. The carrier components required in the formulation of atorvastatin calcium with SNEDDS formulation include oils (oleic acid, peceol, capyrol 90, and capmul CMC), surfactants (tween 80, tween 20, labrasol, cremophor RH 40) and co-surfactants (brij 30, propylene glycol, transcutol-P, PEG 400, transcutol HP). Characterization of atorvastatin calcium with SNEDDS formulation showed droplet size 21.6-162.2 nm; zeta potential -1.32 - 24.6±6.47 mV; and polydensity index 0.164 - 0.297. SNEDDS formulation increased the percentage of drug release and increased the bioavailability of atorvastatin calcium.

 

Keywords: self-nanoemulsifying drug delivery system, SNEDDS, atorvastatin
                     calcium, formulation, characteristics, dissolution, bioavailability

Full Text:

PDF HTML

References

Nawrocki JW, Weiss SR, Davidson MH, Sprecher DL, Schwartz SL, Lupien P-J, et al. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arteriosclerosis, thrombosis, and vascular biology. 1995;15(5):678-82.

Smilde TJ, van Wissen S, Awollersheim H, Trip MD, Kastelein J, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. The Lancet. 2001;357(9256):577-81.

Ching AT, Lim H. A structural model of correlated learning and late-mover advantages: The case of statins. Management Science. 2020;66(3):1095-123.

Lau YY, Okochi H, Huang Y, Benet LZ. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug metabolism and disposition. 2006;34(7):1175-81.

Shete G, Puri V, Kumar L, Bansal AK. Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. AAPS PharmSciTech. 2010;11(2):598-609.

Porter CJ, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Advanced drug delivery reviews. 2008;60(6):673-91.

Morakul B. Self-nanoemulsifying drug delivery systems (SNEDDS): an advancement technology for oral drug delivery. Pharmaceutical Sciences Asia. 2020;47(3).

Makadia HA, Bhatt AY, Parmar RB, Paun JS, Tank H. Self-nano emulsifying drug delivery system (SNEDDS): future aspects. Asian Journal of Pharmaceutical Research. 2013;3(1):21-7.

Elgart A, Cherniakov I, Aldouby Y, Domb AJ, Hoffman A. Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS): the underlying mechanisms for amiodarone and talinolol. Pharmaceutical research. 2013;30:3029-44.

Saroj S, Baby DA, Sabitha M. Current trends in lipid based delivery systems and its applications in drug delivery. Asian journal of pharmaceutical and clinical research. 2012;5(Suppl 3):4-9.

RI DK. Farmakope Indonesia: Departemen Kesehatan RI; 2020.

Deshmukh AS, Mahajan VR. Advanced delivery of poorly water soluble drug atorvastatin by lipid based formulation. Asian journal of pharmaceutical research and development. 2015:21-38.

Uddin MS, Millat MS, Siddiqui SA. Formulation and evaluation studies of Atorvastatin calcium sustained release tablet. PharmaTutor. 2019;7(9):1-5.

Davis AM, Leeson PD. Physicochemical Properties. In: Ward SE, Davis A, editors. The Handbook of Medicinal Chemistry: The Royal Society of Chemistry; 2023. p. 0.

Kassem AM, Ibrahim HM, Samy AM. Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: In vitro and in vivo evaluation. Journal of Microencapsulation. 2017;34(3):319-33.

Convention TUSP. Atorvastatin: The United States Pharmacopeial Convention; 2013 [

Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced drug delivery reviews. 2007;59(7):617-30.

Venkatesh M, Mallesh K. Self-nano emulsifying drug delivery system (SNEDDS) for oral delivery of atorvastatin-formulation and bioavailability studies. Journal of Drug Delivery and Therapeutics. 2013;3(3):131-40.

Hashem FM, Al-Sawahli MM, Nasr M, Ahmed OA. Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems–enhancement of oral bioavailability. Drug design, development and therapy. 2015:3141-52.

Tarkase K, Damale P, Kapare P, Lagad V. Formulation and evaluation of supersaturable self nano-emulsifying drug delivery system of poorly water soluble atorvastatin calcium. Asian Journal of Pharmaceutical Research and Development. 2014:22-33.

Reddy MS. Formulation and in vitro characterization of solid-self nanoemulsifying drug delivery system of atorvastatin calcium. Asian Journal of Pharmaceutics (AJP). 2017;11(04).

Gardouh AR, Nasef AM, Mostafa Y, Gad S. Design and evaluation of combined atorvastatin and ezetimibe optimized self-nano emulsifying drug delivery system. Journal of Drug Delivery Science and Technology. 2020;60:102093.

Limbani MD, Patel L. FORMULATION AND EVALUATION OF SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM CONTAINING POORLY WATER SOLUBLE ANTILIPIDEMIC DRUGS. 2018.

Bandivadekar M, Pancholi S, Kaul-Ghanekar R, Choudhari A, Koppikar S. Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study. Drug Development and Industrial Pharmacy. 2013;39(5):696-703.

Mohsin K, Alamri R, Ahmad A, Raish M, Alanazi FK, Hussain MD. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. International journal of nanomedicine. 2016:2829-38.

Mahdi L, Sudibyo RS, Martien R. Self-nano emulsifying drug delivery system (SNEDDS) of curcuma mangga Val. essential oil and the stability study. Indones J Pharm. 2020;31(4):238-43.

Rajinikanth P, Keat NW, Garg S. Self-nanoemulsifying drug delivery systems of Valsartan: preparation and in-vitro characterization. International journal of drug delivery. 2012;4(2):153.

DOI: https://doi.org/10.24198/idjp.v5i2.50996

Refbacks

  • There are currently no refbacks.